We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+4.43%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.16B
AUM Growth
-$602M
(-7.8%)
Cap. Flow
-$898M
Cap. Flow
% of AUM
-12.54%
Top 10 Holdings %
Top 10 Hldgs %
13.65%
Holding
1,599
New
18
Increased
215
Reduced
1,222
Closed
140
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Franklin Resources
BEN
|
+$14.7M |
| 2 |
Target
TGT
|
+$11.7M |
| 3 |
W.W. Grainger
GWW
|
+$11.6M |
| 4 |
Cardinal Health
CAH
|
+$10.5M |
| 5 |
PPG Industries
PPG
|
+$10.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$94.4M |
| 2 |
Microsoft
MSFT
|
+$70.8M |
| 3 |
Amazon
AMZN
|
+$47.6M |
| 4 |
Meta Platforms (Facebook)
META
|
+$44.1M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$39.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.28% |
| 2 | Financials | 14.57% |
| 3 | Consumer Staples | 12.48% |
| 4 | Technology | 10.87% |
| 5 | Industrials | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DRNA
1426
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $77K | ﹤0.01% |
13,089
-2,339
| -15% | -$8.2K |
|
|
NEOS
1427
DELISTED
Neos Therapeutics, Inc
NEOS
| $76K | ﹤0.01% |
11,490
-2,132
| -16% | -$16.9K |
|
1428
Scorpio Tankers
STNG
$3.88B
| $75K | ﹤0.01% |
1,614
-386
| -19% | -$18.6K |
|
|
CSR
1429
Centerspace
CSR
$939M
| $71K | ﹤0.01% |
1,196
-286
| -19% | -$18.2K |
|
1430
Alaunos Therapeutics
TCRT
$4.96M
| $68K | ﹤0.01% |
80
-19
| -19% | -$15.3K |
|
1431
TETRA Technologies
TTI
$1.31B
| $66K | ﹤0.01% |
10,757
-930
| -8% | -$5.66K |
|
1432
Larimar Therapeutics
LRMR
$398M
| $65K | ﹤0.01% |
1,624
-301
| -16% | -$13.7K |
|
|
ADAM
1433
Adamas Trust
ADAM
$793M
| $65K | ﹤0.01% |
2,717
-648
| -19% | -$16K |
|
|
ELNK
1434
DELISTED
EarthLink Holdings Corp.
ELNK
| $64K | ﹤0.01% |
10,376
-2,479
| -19% | -$16K |
|
1435
Manitowoc
MTW
$459M
| $62K | ﹤0.01% |
3,221
-930
| -22% | -$18.8K |
|
|
AFMD
1436
DELISTED
Affimed
AFMD
| $58K | ﹤0.01% |
2,098
-378
| -15% | -$10.6K |
|
|
INFI
1437
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $56K | ﹤0.01% |
36,117
-6,698
| -16% | -$10.3K |
|
|
CIE
1438
DELISTED
Cobalt International Energy, Inc
CIE
| $55K | ﹤0.01% |
2,942
-2,452
| -45% | -$45.5K |
|
|
AEGR
1439
DELISTED
Aegerion Pharmaceuticals
AEGR
| $55K | ﹤0.01% |
18,615
-3,345
| -15% | -$5.8K |
|
|
ATYR
1440
aTyr Pharma
ATYR
$47.7M
| $48K | ﹤0.01% |
1,068
-191
| -15% | -$8.25K |
|
|
COOP
1441
DELISTED
Mr. Cooper
COOP
| $47K | ﹤0.01% |
1,671
-399
| -19% | -$11.2K |
|
1442
Extreme Networks
EXTR
$3.96B
| $46K | ﹤0.01% |
10,207
-2,436
| -19% | -$9.61K |
|
|
CHMA
1443
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $45K | ﹤0.01% |
15,361
-2,733
| -15% | -$7.49K |
|
1444
Arcturus Therapeutics
ARCT
$170M
| $43K | ﹤0.01% |
2,483
-448
| -15% | -$14.5K |
|
|
MWW
1445
DELISTED
Monster Worldwide Inc
MWW
| $38K | ﹤0.01% |
10,415
-2,292
| -18% | -$7.3K |
|
|
COWN
1446
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $37K | ﹤0.01% |
2,522
-602
| -19% | -$7.98K |
|
|
SRRA
1447
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $35K | ﹤0.01% |
478
-84
| -15% | -$6.49K |
|
1448
Option Care Health
OPCH
$3.42B
| $32K | ﹤0.01% |
+2,776
| New | +$29.9K |
|
1449
Plug Power
PLUG
$2.97B
| $30K | ﹤0.01% |
17,835
-4,257
| -19% | -$7.07K |
|
|
AT
1450
DELISTED
Atlantic Power Corporation
AT
| $30K | ﹤0.01% |
12,041
-2,875
| -19% | -$7.24K |
|
Similar funds
ProShare Advisors's Q3 2016 Portfolio in Review
As of Q3 2016, ProShare Advisors held 1,599 positions worth $7.16B, down 7.8% from $7.76B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
ProShare Advisors withdrew a net $898M in Q3 2016, closing 140 positions and reducing 1,222 holdings. Its most notable exit was MEDIVATION, INC., an estimated $7.72M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Staples.
Against the trend, ProShare Advisors opened a new position in Fortive worth $1.07M.
- ProShare Advisors's largest Q3 2016 buy was Fortive: 33,277 shares worth $1.07M.
- ProShare Advisors added most to Franklin Resources in Q3 2016, an estimated $14.7M increase.
- ProShare Advisors's biggest Q3 2016 reduction was Apple, cutting an estimated $94.4M.
- ProShare Advisors fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.72M.
- ProShare Advisors's ten largest holdings make up 14% of its $7.16B portfolio in Q3 2016.
- ProShare Advisors opened 18 new positions and closed 140 in Q3 2016.
- ProShare Advisors's portfolio value fell 7.8% quarter-over-quarter to $7.16B.
Based on ProShare Advisors's 13F filing for Q3 2016, filed 10 Nov 2016.